مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

15,616
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

EFFECT OF LONG-TERM CONTINUOUS METHIMAZOLE TREATMENT OF THYROTOXICOSISI: COMPARISON WITH RADIOIODINE

Pages

  466-475

Abstract

 Introduction: The major complication of RADIOIODINE therapy for thyrotoxicosis is hypothyroidism, the long-term management of which is often problematic. In this study, the long-term effects of continuous METHIMAZOLE (MMI) therapy are investigated.Materials and Methods: One hundred and thirty-two patients, aged between 36-66 years, with Graves RECURRENCE, were semi randomly randomized in 2 groups for continuous antithyroid and RADIOIODINE treatment. The number of thyroid dysfunctions in each patient were recorded and serum TSH, FT4, Anti TPO, TRAb, FBS, HOMA IR, and lipid profiles were measured. Bone mineral density and echocardiography were performed.Results: There was no significant differences in age, duration of symptoms and thyroid function between the 2 groups. No serious COMPLICATIONS occurred in the MMI group and no difference in any of parameters was seen between groups 1 and 2. Goiter rate and anti TPO concentration were higher in group 1 than in group 2. Serum triglycerides and cholesterol were increased in group 2 as compared to group 1. Bone mineral density was more reduced in group 2, especially in the spine. Echocardiography showed diastolic dysfunction in group 2 as compared to group 1. Some parameters in neuro-pschyciatric evaluation were significantly better in the MMI group, as compared to the RADIOIODINE one.Conclusion: Considering it is a safe treatment and has fewer COMPLICATIONS, METHIMAZOLE is another option for patients with recurrent Graves', who do not wish to use RADIOIODINE.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    YOUSEFI, V., BAHREYNIAN, A., SHEIKHOLESLAMI, F., TOHIDI, M., MEHRABI, Y., & AZIZI, F.. (2011). EFFECT OF LONG-TERM CONTINUOUS METHIMAZOLE TREATMENT OF THYROTOXICOSISI: COMPARISON WITH RADIOIODINE. IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM), 12(5 (SN 53)), 466-475. SID. https://sid.ir/paper/27180/en

    Vancouver: Copy

    YOUSEFI V., BAHREYNIAN A., SHEIKHOLESLAMI F., TOHIDI M., MEHRABI Y., AZIZI F.. EFFECT OF LONG-TERM CONTINUOUS METHIMAZOLE TREATMENT OF THYROTOXICOSISI: COMPARISON WITH RADIOIODINE. IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM)[Internet]. 2011;12(5 (SN 53)):466-475. Available from: https://sid.ir/paper/27180/en

    IEEE: Copy

    V. YOUSEFI, A. BAHREYNIAN, F. SHEIKHOLESLAMI, M. TOHIDI, Y. MEHRABI, and F. AZIZI, “EFFECT OF LONG-TERM CONTINUOUS METHIMAZOLE TREATMENT OF THYROTOXICOSISI: COMPARISON WITH RADIOIODINE,” IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM), vol. 12, no. 5 (SN 53), pp. 466–475, 2011, [Online]. Available: https://sid.ir/paper/27180/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top